Cargando…
A VEGF-dependent gene signature enriched in mesenchymal ovarian cancer predicts patient prognosis
We have previously reported surrogate biomarkers of VEGF pathway activities with the potential to provide predictive information for anti-VEGF therapies. The aim of this study was to systematically evaluate a new VEGF-dependent gene signature (VDGs) in relation to molecular subtypes of ovarian cance...
Autores principales: | Yin, Xia, Wang, Xiaojie, Shen, Boqiang, Jing, Ying, Li, Qing, Cai, Mei-Chun, Gu, Zhuowei, Yang, Qi, Zhang, Zhenfeng, Liu, Jin, Li, Hongxia, Di, Wen, Zhuang, Guanglei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976329/ https://www.ncbi.nlm.nih.gov/pubmed/27498762 http://dx.doi.org/10.1038/srep31079 |
Ejemplares similares
-
Stroma-associated master regulators of molecular subtypes predict patient prognosis in ovarian cancer
por: Zhang, Shengzhe, et al.
Publicado: (2015) -
PAX8 regulon in human ovarian cancer links lineage dependency with epigenetic vulnerability to HDAC inhibitors
por: Shi, Kaixuan, et al.
Publicado: (2019) -
Concomitant BET and MAPK blockade for effective treatment of ovarian cancer
por: Jing, Ying, et al.
Publicado: (2015) -
BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1
por: Zhang, Zhenfeng, et al.
Publicado: (2016) -
Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors
por: Zhang, Shengzhe, et al.
Publicado: (2018)